Lack of effect of TFPIC127 on125I-TFPI binding and degradation in HepG2 cells
Competitor (nmol) . | 125I-TFPI Degraded (fmol/106 c/4 h)* . |
---|---|
None | 106 |
TFPI (500) | 33 |
TFPIC127 (500) | 107 |
RAP (1000) | 22 |
Competitor (nmol) | 125I-TFPI Bound (fmol/106 c)† |
None | 5246 |
TFPI (500) | 640 |
TFPIC127 (500) | 5234 |
RAP (400) | 5093 |
Competitor (nmol) . | 125I-TFPI Degraded (fmol/106 c/4 h)* . |
---|---|
None | 106 |
TFPI (500) | 33 |
TFPIC127 (500) | 107 |
RAP (1000) | 22 |
Competitor (nmol) | 125I-TFPI Bound (fmol/106 c)† |
None | 5246 |
TFPI (500) | 640 |
TFPIC127 (500) | 5234 |
RAP (400) | 5093 |
HepG2 cells in monolayer were washed and incubated at 37°C for 4 h with media containing 0.6 nmol 125I-TFPI in the presence or absence of the indicated competitors. Thereafter, the media was removed and assayed for 125I-TFPI degradation products as described in the text. Each value represents the mean of triplicate determinations.
HepG2 cells in monolayer were washed and incubated at 4°C for 2 h with media containing 20 nmol 125I-TFPI in the presence or absence of the indicated competitors. Thereafter, the media was removed, the cells rinsed and cell-surface bound 125I-TFPI was determined as described in the text. Each value represents the mean of triplicate determinations.